MICHAEL R. BRISTOW, M.D., PH.D. - Corporate Board Profile

Oruka Therapeutics, Inc.

Filing Date	Source Excerpt
2009-04-30	Michael R. Bristow, M.D., Ph.D. Dr. Bristow has served as the Company 2 Chief Science and Medical Officer and a director since our merger with ARCA Colorado. Mr. Brewer has also served as a director of ARCA Colorado since November 2006. Dr. Bristow was one of the founders of ARCA Colorado in September 2004, and served as its Chairman and Chief Executive Officer from that date until he was appointed to the position of Chief Science and Medical Officer in November 2006. Dr. Bristow is a Professor of Medicine and the former Head of Cardiology at the University of Colorado Health Sciences Center, where he has been since October 1991.
2010-04-07	Dr. Bristow, age 65, has served as the Company 27s President and Chief Executive Officer since July 2009. Prior to that time, Dr. Bristow served as the Company 27s Chief Science and Medical Officer and a director since the merger with Nuvelo. Dr. Bristow has also served as a director of ARCA Colorado since November 2006. Dr. Bristow was one of the founders of ARCA Colorado in September 2004, and served as its Chairman and Chief Executive Officer from that date until he was appointed to the position of Chief Science and Medical Officer in November 2006.
2011-03-30	Dr. Bristow, age 66, has served as the Company 27s President and Chief Executive Officer since July 2009. ... The following table shows for the fiscal years ended December 31, 2009 and December 31, 2010, compensation awarded to, paid to, or earned by the Company 27s principal executive officers and its other named executive officers as of December 31, 2010, collectively, the Named Executive Officers: ... Michael R. Bristow, President and Chief Executive Officer 2010 Salary ($) 265,000 Option Awards($)(1) 33,038 All Other Compensation ($) 10,192 Total ($) 308,230.
2012-04-05	Dr. Bristow, age 67, has served as the Companys President and Chief Executive Officer since July 2009. ... Summary Compensation Table for fiscal 2011 shows Michael R. Bristow, President and Chief Executive Officer with total compensation of $338,618.
2013-02-01	Michael R. Bristow, M.D., Ph.D. is listed as a director and named executive officer with beneficial ownership of 1,798,984 shares. No specific age, committees, or compensation details are provided.
2013-08-01	Dr. Bristow, age 68, has served as the Company 27s President and Chief Executive Officer since July 2009. ... Dr. Bristow is an appropriate member of the Company 27s Board of Directors given his extensive experience and expertise as a cardiologist, medical researcher and drug developer in the field of cardiovascular medicine, and heart failure specifically, and his experience as a founder and manager of a cardiovascular-focused, public pharmaceutical company. ... The following table shows for the fiscal years ended December 31, 2011 and December 31, 2012, compensation awarded to, paid to, or earned by the Company 27s principal executive officers and its other named executive officers as of December 31, 2012, collectively, the Named Executive Officers: ... Michael R. Bristow, President and Chief Executive Officer 2012 Salary ($) 246,705, Bonus ($) 13,304, All Other Compensation ($) 9,868, Total ($) 269,877.
2014-04-15	Dr. Bristow, age 69, has served as the Company 27s President and Chief Executive Officer since July 2009. ... Dr. Bristow also has extensive experience with, and knowledge of, ARCA 27s business, as the founder and former Chief Science and Medical Officer of ARCA Colorado, and the current President and Chief Executive Officer of ARCA, and as a Board member of ARCA Colorado since 2005, and of the Company since January 2009. ... The following table shows for the fiscal years ended December 31, 2012 and December 31, 2013, compensation awarded to, paid to, or earned by the Company 27s principal executive officers and its other named executive officers as of December 31, 2013, collectively, the Named Executive Officers: ... Michael R. Bristow, President and Chief Executive Officer ... Total($) 872,189.
2015-04-14	Dr. Bristow, age 70, has served as the Company’s President and Chief Executive Officer since July 2009. Prior to that time, Dr. Bristow served as the Company’s Chief Science and Medical Officer and a director since the merger with Nuvelo. Dr. Bristow was one of the founders of ARCA Colorado in September 2004, and served as its Chairman and Chief Executive Officer from that date until he was appointed to the position of Chief Science and Medical Officer in November 2006. Dr. Bristow is a Professor of Medicine and the former Head of Cardiology at the University of Colorado Health Sciences Center, where he has been since October 1991. Dr. Bristow was one of the founders of Myogen, Inc. and served as Myogen’s Chief Science and Medical Officer from October 1996 to February 2006 and as a Scientific Advisor to Myogen from February 2006 until the acquisition of Myogen by Gilead Sciences, Inc. in November 2006. Dr. Bristow is an appropriate member of the Company’s Board of Directors given his extensive experience and expertise as a cardiologist, medical researcher and drug developer in the field of cardiovascular medicine, and heart failure specifically, and his experience as a founder and manager of cardiovascular-focused, public pharmaceutical company. Dr. Bristow also has extensive experience with, and knowledge of, ARCA’s business, as the founder and former Chief Science and Medical Officer of ARCA Colorado, and the current President and Chief Executive Officer of ARCA, and as a Board member of ARCA Colorado since 2005, and of the Company since January 2009.
2016-04-27	Dr. Bristow, age 71, was one of the founders of ARCA in September 2004, and has served as a Director since that time. Dr. Bristow has also served as the Companys President and Chief Executive Officer since July 2009. ... Dr. Bristow, our President and Chief Executive Officer, was also a director during the year ended December 31, 2015, but did not receive any additional compensation for his service as a director. Dr. Bristows compensation as an executive officer is set forth above under Executive CompensationSummary Compensation Table.
2017-04-21	Dr. Bristow, age 72, was one of the founders of ARCA in September 2004, and has served as a Director since that time. Dr. Bristow has also served as the Companys President and Chief Executive Officer since July 2009. ... Dr. Bristows compensation as an executive officer is set forth above under Executive CompensationSummary Compensation Table.
2018-04-18	Dr. Bristow, age 73, was one of the founders of ARCA in September 2004, and has served as a Director since that time. Dr. Bristow has also served as the Company’s President and Chief Executive Officer since July 2009. Previously, Dr. Bristow served as the President and Chief Executive Officer of the Company from September 2004 to November 2006, and as the Company’s Chief Science and Medical Officer from November 2006 to July 2009. Dr. Bristow is a Professor of Medicine and the former Head of Cardiology at the University of Colorado Health Sciences Center, where he has been since October 1991. Dr. Bristow was one of the founders of Myogen, Inc. and served as Myogen’s Chief Science and Medical Officer from October 1996 to February 2006 and as a Scientific Advisor to Myogen from February 2006 until the acquisition of Myogen by Gilead Sciences, Inc. in November 2006. We believe Dr. Bristow is an appropriate member of the Company’s Board of Directors given his extensive experience and expertise as a cardiologist, medical researcher and drug developer in the field of cardiovascular medicine, and heart failure specifically, and his experience as a founder and manager of cardiovascular-focused, public pharmaceutical company. Dr. Bristow also has extensive experience with, and knowledge of, ARCA’s business, as the founder and former Chief Science and Medical Officer of the Company, and the current President and Chief Executive Officer of ARCA, and as a member of the Board of Directors of ARCA since the founding of the Company. Dr. Bristow holds a M.D. and Ph.D. from the University of Illinois. Dr. Bristow, our President and Chief Executive Officer, was also a director during the year ended December 31, 2017, but did not receive any additional compensation for his service as a director. Dr. Bristow’s compensation as an executive officer is set forth above under Executive Compensation—Summary Compensation Table.
2018-09-20	The following table sets forth certain information regarding the ownership of the Companys Common Stock as of the August 31, 2018, by: (i) each director and nominee for director, (ii) each of our named executive officers, (iii) all executive officers and directors of the Company as a group, and (iv) all those known by the Company to be beneficial owners of more than five percent of its Common Stock.
2019-10-25	Dr. Bristow, age 74, was one of the founders of ARCA in September 2004, and has served as a Director since that time. Dr. Bristow has also served as the Company’s President and Chief Executive Officer since July 2009. ... Executive Compensation ... Michael R. Bristow ... Total ... $320,490.
2020-10-28	Michael R. Bristow, M.D., Ph.D. Dr. Bristow, age 75, was one of the founders of ARCA in September 2004, and has served as a Director since that time. Dr. Bristow has also served as the Company’s President and Chief Executive Officer since July 2009. ... Dr. Bristow’s compensation as an executive officer is set forth above under “Executive Compensation—Summary Compensation Table.” Total compensation for 2019 was $296,151.
2021-04-21	Dr. Bristow, age 76, was one of the founders of ARCA in September 2004, and has served as a Director since that time. Dr. Bristow has also served as the Company’s President and Chief Executive Officer since July 2009. ... Dr. Bristow, our President and Chief Executive Officer, was also a director during the year ended December 31, 2020, but did not receive any additional compensation for his service as a director. Dr. Bristow’s compensation as an executive officer is set forth above under “Executive Compensation—Summary Compensation Table.” ...
2022-11-03	Dr. Bristow, age 77, was one of the founders of ARCA in September 2004, and has served as a Director since that time. Dr. Bristow has also served as the Company’s President and Chief Executive Officer since July 2009. ... Dr. Bristow is an appropriate member of the Company’s Board of Directors given his extensive experience and expertise as a cardiologist, medical researcher and drug developer in the field of cardiovascular medicine, and heart failure specifically, and his experience as a founder and manager of a cardiovascular-focused, public pharmaceutical company. ... Director Compensation ... Dr. Bristow, our President and Chief Executive Officer, was also a director during the year ended December 31, 2021, but did not receive any additional compensation for his service as a director. Dr. Bristow’s compensation as an executive officer is set forth above under “Executive Compensation—Summary Compensation Table.” ... Summary Compensation Table for Fiscal 2021 ... Michael R. Bristow ... Total ($) 526,513.
2023-12-19	Dr. Bristow, age 78, was one of the founders of ARCA in September 2004, and has served as a Director since that time. Dr. Bristow has also served as the Company’s President and Chief Executive Officer since July 2009. ... Dr. Bristow’s compensation as an executive officer is set forth above under “Executive Compensation—Summary Compensation Table.” Total compensation for 2022 was $358,800.